Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: Singapore Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20073
20083
20101
20131
20151
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Pfizer3
Hoffmann-La Roche2
National University Hospital, Singapore2
Bristol-Myers Squibb1
Coherus Oncology, Inc.1
GlaxoSmithKline1
Hoosier Cancer Research Network1
Sichuan Huiyang Life Science and Technology Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell15
Kidney Neoplasms4
Carcinoma, Hepatocellular3
Carcinoma, Non-Small-Cell Lung3
Neoplasms2
Adenocarcinoma1
Adenoma, Islet Cell1
Breast Neoplasms1
Carcinoma1
Colonic Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.